Provided by Tiger Trade Technology Pte. Ltd.

ALPHA COGNITION INC

5.34
+0.02000.38%
Pre-market: 5.29-0.0500-0.94%08:24 EDT
Volume:59.68K
Turnover:313.22K
Market Cap:116.10M
PE:-4.02
High:5.48
Open:5.26
Low:5.04
Close:5.32
52wk High:11.54
52wk Low:3.75
Shares:21.74M
Float Shares:15.06M
Volume Ratio:1.85
T/O Rate:0.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3296
EPS(LYR):-2.0195
ROE:-125.65%
ROA:-42.20%
PB:3.42
PE(LYR):-2.64

Loading ...

Opaleye Management reports acquisition of Alpha Cognition common shares; value rises to $110,000

Reuters
·
13 hours ago

Alpha Cognition FY2025 operating loss widened to $23 million; revenue rose to $10.2 million

Reuters
·
16 hours ago

Alpha Cognition Q4 EPS $(0.30) Misses $(0.27) Estimate, Sales $2.793M Miss $3.197M Estimate

Benzinga
·
16 hours ago

Alpha Cognition reports FY25 EPS ($1.17) vs. ($2.04) last year

TIPRANKS
·
16 hours ago

Press Release: Alpha Cognition Inc. Reports Fiscal 2025 Financial Results and Provides Operational Update

Dow Jones
·
16 hours ago

On National Viagra Day, Women Finally Claim Their Turn:

GlobeNewswire
·
Mar 23

Opaleye Management Inc. acquired USD 7,695 of Alpha Cognition common shares

Reuters
·
Mar 19

Opaleye Management Inc. reports acquisition of Alpha Cognition common shares

Reuters
·
Mar 14

Alpha Cognition to Report Q4 and Full-Year 2025 Results and Host Conference Call

Reuters
·
Mar 14

Alpha Cognition (Nasdaq: Acog) to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on Thursday, March 26, 2026

THOMSON REUTERS
·
Mar 14

Alpha Cognition to Present New ZUNVEYL Clinical Data at AAGP and NEI Conferences

Reuters
·
Mar 10

Opaleye Management Inc. reports acquisition of Alpha Cognition common shares

Reuters
·
Mar 05

Alpha Cognition enrolls first patient in BEACON Phase 4 real-world ZUNVEYL study

Reuters
·
Feb 25

Alpha Cognition Announces First Patient Enrolled in Beacon Real-World Effectiveness Study

THOMSON REUTERS
·
Feb 25

Opaleye Management Inc. Acquires Alpha Cognition Common Shares

Reuters
·
Feb 25

Alpha Cognition Director Len Mertz to Step Down After 2026 Annual Meeting

Reuters
·
Feb 24

Opaleye Management Inc. Files Alpha Cognition Initial Statement of Beneficial Ownership

Reuters
·
Feb 21

Alpha Cognition Says USPTO Issues New U.S. Patent Covering ZUNVEYL Dosing Regimens

Reuters
·
Feb 18

Alpha Cognition Announces Issuance of Additional U.S. Patent Covering Zunveyl ® Dosing Regimens

THOMSON REUTERS
·
Feb 18

Alpha Cognition Inc - Patent Expected to Provide U.S. Protection Through July 2045

THOMSON REUTERS
·
Feb 18